Cefuroxime Axetil

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

59 Suppliers, 40 USDMF, 20 CEP/COS, 11 EU WC, 24 KDMF, 4 NDC API, 16 Listed Suppliers

DEVELOPMENTS

2 Drug(s) in Development

2 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

1 Suppliers

1 Suppliers

DOSSIERs // Finished Dosage Forms

216 Dossiers, 34 FDA Orange Book, 113 Europe, 5 Canada, 8 South Africa, 56 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION;ORAL - EQ 125MG BASE/5ML, FOR SUSPENSION;ORAL - EQ 250MG BASE/5ML

RELATED EXCIPIENT COMPANIES

Suppliers, 20 Roquette, 19 SPI Pharma, 19 BASF, 17 Kerry, 14 Microlex e.U, 14 Seppic, 12 Corel Pharma Chem, 10 Sigachi Industries, 10 Gangwal Healthcare, 9 Gangwal Chemicals, 9 Ideal Cures Pvt Ltd, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Actylis, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 Lonza Capsugel, 4 Ingredion Pharma Solutions, 4 Nanjing Well Pharmaceutical, 4 Vasa Pharmachem, 4 Rochem International Inc, 4 DKSH, 3 DFE Pharma, 3 Kima Chemical, 3 Prachin Chemical, 2 Seqens, 2 Finar, 2 Pfanstiehl, 2 Jai Radhe Sales, 2 Nomisma Healthcare, 2 The Dow Chemical Company, 2 Aeon Procare, 2 Clariant, 2 Boai NKY Pharmaceuticals Ltd, 1 Evonik, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Alcedo Pharmachem, 1 Vertellus, 1 Ulanqab Kema New Material, 1 Nanjing Bold Chemical, 1 ACG Worldwide, 1 Avesta Pharma, 1 Pharmatrans-Sanaq, 1 Qualicaps, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Pharm-RX Chemical, 1 Shijiazhuang Huaxu Pharmaceutical

EXCIPIENTS BY APPLICATIONS

60 Fillers, Diluents & Binders, 55 Coating Systems & Additives, 34 Direct Compression, 32 Controlled & Modified Release, 26 Lubricants & Glidants, 25 Thickeners and Stabilizers, 23 Taste Masking, 20 Disintegrants & Superdisintegrants, 19 Solubilizers, 18 Granulation, 18 Chewable & Orodispersible Aids, 17 Topical, 16 Parenteral, 15 Film Formers & Plasticizers, 14 Co-Processed Excipients, 9 Emulsifying Agents, 8 API Stability Enhancers, 5 Empty Capsules, 5 Rheology Modifiers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 2 Coloring Agents

GLOBAL SALES INFORMATION

9 US Medicaid Prescriptions, 113 Finished Drug Prices

MARKET PLACE

23 APIs, 30 DOSSIERS // FDF

PATENTS

9 Health Canada Patents

9 Health Canada Patents

ANALYTICAL SOLUTION(s)

2 BioAnalytical Methods, 1 EDQM Standards, 3 USP Standards, 5 Other Ref. Standards

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 11 News

Approved Drug Products containing Cefuroxime Axetil listed with Health Canada. Original Data : Health Canada Website

Cefuroxime Axetil

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

59 Suppliers

40 USDMF

20 CEP/COS

11 EU WC

24 KDMF

4 NDC API

16 Listed Suppliers

DEVELOPMENTS

2 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

1 Suppliers

DOSSIERs // Finished Dosage Forms

216 Dossiers

34 FDA Orange Book

113 Europe

5 Canada

8 South Africa

56 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FOR SUSPENSION;ORAL - EQ 125MG BASE/5ML

FOR SUSPENSION;ORAL - EQ 250MG BASE/5ML

RELATED EXCIPIENT COMPANIES

Suppliers

20 Roquette

19 SPI Pharma

19 BASF

17 Kerry

14 Microlex e.U

14 Seppic

12 Corel Pharma Chem

10 Sigachi Industries

10 Gangwal Healthcare

9 Gangwal Chemicals

9 Ideal Cures Pvt Ltd

8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

8 Actylis

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

6 Lonza Capsugel

4 Ingredion Pharma Solutions

4 Nanjing Well Pharmaceutical

4 Vasa Pharmachem

4 Rochem International Inc

4 DKSH

3 DFE Pharma

3 Kima Chemical

3 Prachin Chemical

2 Seqens

2 Finar

2 Pfanstiehl

2 Jai Radhe Sales

2 Nomisma Healthcare

2 The Dow Chemical Company

2 Aeon Procare

2 Clariant

2 Boai NKY Pharmaceuticals Ltd

1 Evonik

1 Shanghai Welltone Material Technology Co., Ltd

1 Alcedo Pharmachem

1 Vertellus

1 Ulanqab Kema New Material

1 Nanjing Bold Chemical

1 ACG Worldwide

1 Avesta Pharma

1 Pharmatrans-Sanaq

1 Qualicaps

1 Qianhao Chemical (Hebei) Co., Ltd

TABLET;ORAL - EQ 125MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 250MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 500MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons